Caffeine

咖啡因

Report date: 2022/08/25 14:21:50
NME

Base Information

Drug NameCaffeine
Drug Alias NameRespia茶精咖啡硷咖啡碱
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdenosine A1 receptor antagonistsAdenosine A2a receptor antagonists
TargetsAdenosine A1 receptorAdenosine A2a receptor
Therapy Area/IndicationsCognitive DysfunctionConsciousnessCocaine-Related Disorders +[19
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesDenmark +[4
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active IndicationsCognitive DysfunctionConsciousnessCocaine-Related Disorders +[15
Inactive IndicationsIntermittent ClaudicationFetal Membranes, Premature RuptureDisorders of Excessive Somnolence +[4

Other Information

ATC CodeN06BC01